H2BC11

gene
On this page

Also known as H2B/r

Summary

H2BC11 (H2B clustered histone 11, HGNC:4761) is a protein-coding gene on chromosome 6p22.1, encoding Histone H2B type 1-J (P06899). Core component of nucleosome. It is a common-essential gene (DepMap: required in 99.4% of cancer cell lines).

Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Two molecules of each of the four core histones (H2A, H2B, H3, and H4) form an octamer, around which approximately 146 bp of DNA is wrapped in repeating units, called nucleosomes. The linker histone, H1, interacts with linker DNA between nucleosomes and functions in the compaction of chromatin into higher order structures. This gene is intronless and encodes a replication-dependent histone that is a member of the histone H2B family. Transcripts from this gene lack polyA tails but instead contain a palindromic termination element. This gene is found in the histone microcluster on chromosome 6p21.33.

Source: NCBI Gene 8970 — RefSeq curated summary.

At a glance

  • GWAS associations: 24
  • Clinical variants (ClinVar): 25 total
  • Cancer dependency (DepMap): dependent in 99.4% of screened cell lines (common-essential)
  • MANE Select transcript: NM_021058

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:4761
Approved symbolH2BC11
NameH2B clustered histone 11
Location6p22.1
Locus typegene with protein product
StatusApproved
AliasesH2B/r
Ensembl geneENSG00000124635
Ensembl biotypeprotein_coding
OMIM615044
Entrez8970

Gene structure

Transcript identifiers

Ensembl transcripts: 4 — 4 protein_coding

ENST00000339812, ENST00000606923, ENST00000607124, ENST00000939860

RefSeq mRNA: 1 — MANE Select: NM_021058 NM_021058

CCDS: CCDS4618

Canonical transcript exons

ENST00000339812 — 1 exons

ExonStartEnd
ENSE000022558332713231627132795

Expression profiles

Bgee: expression breadth ubiquitous, 138 present calls, max score 98.73.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 246.8781 / max 6879.1525, expressed in 1813 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
72355246.87811813

Top tissues by expression

153 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
bone marrow cellCL:000209298.73gold quality
monocyteCL:000057695.66gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047395.39gold quality
calcaneal tendonUBERON:000370195.28gold quality
leukocyteCL:000073894.51gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099193.45gold quality
left testisUBERON:000453393.15gold quality
right testisUBERON:000453493.09gold quality
testisUBERON:000047392.57gold quality
adrenal tissueUBERON:001830392.38gold quality
bloodUBERON:000017889.87gold quality
bone marrowUBERON:000237187.18gold quality
granulocyteCL:000009483.13gold quality
lower esophagus mucosaUBERON:003583481.99gold quality
corpus callosumUBERON:000233680.58gold quality
tonsilUBERON:000237280.39gold quality
colonic epitheliumUBERON:000039779.88gold quality
mucosa of transverse colonUBERON:000499178.25gold quality
vaginaUBERON:000099678.11gold quality
spleenUBERON:000210677.99gold quality
right lungUBERON:000216777.73gold quality
esophagus mucosaUBERON:000246976.23gold quality
gastrocnemiusUBERON:000138876.12gold quality
muscle of legUBERON:000138375.98gold quality
C1 segment of cervical spinal cordUBERON:000646975.97gold quality
spinal cordUBERON:000224075.74gold quality
prostate glandUBERON:000236774.39gold quality
lungUBERON:000204874.37gold quality
uterine cervixUBERON:000000274.29gold quality
skeletal muscle tissueUBERON:000113473.24gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-CURD-122yes21.36
E-ANND-3yes7.76
E-HCAD-1yes5.56
E-GEOD-124858no12.77

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): E2F1, E2F4, EZH2, HEY1, POU2F1, POU2F2, PPARA, TP53

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 99.4% of screened cell lines, common-essential.

Literature-anchored findings (GeneRIF, showing 2)

  • Histone H2A and H2B antimicrobial peptides exhibit antibacterial activity and endotoxin-neutralizing activity in the placenta. (PMID:11859126)
  • The genes HIST1H2BJ, PRSS16, and PGBD1 were not associated with Japanese patients with schizophrenia. (PMID:22488895)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusH2bc21ENSMUSG00000068854
rattus_norvegicusENSRNOG00000075829

Paralogs (21): H2BW2 (ENSG00000101812), H2BW1 (ENSG00000123569), H2BC1 (ENSG00000146047), H2BC5 (ENSG00000158373), H2BC4 (ENSG00000180596), H2BC21 (ENSG00000184678), H2BC13 (ENSG00000185130), H2BC26 (ENSG00000196890), H2BC12 (ENSG00000197903), H2BC18 (ENSG00000203814), H2BC15 (ENSG00000233822), H2BC12L (ENSG00000234289), H2BC14 (ENSG00000273703), H2BC8 (ENSG00000273802), H2BC6 (ENSG00000274290), H2BC17 (ENSG00000274641), H2BC9 (ENSG00000275713), H2BC3 (ENSG00000276410), H2BC7 (ENSG00000277224), H2BC10 (ENSG00000278588), H2BK1 (ENSG00000285480)

Protein

Protein identifiers

Histone H2B type 1-JP06899 (reviewed: P06899)

Alternative names: Histone H2B.1, Histone H2B.r

All UniProt accessions (2): P06899, U3KPT8

UniProt curated annotations — full annotation on UniProt →

Function. Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. Has broad antibacterial activity. May contribute to the formation of the functional antimicrobial barrier of the colonic epithelium, and to the bactericidal activity of amniotic fluid.

Subunit / interactions. The nucleosome is a histone octamer containing two molecules each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of DNA. Heterodimer H2BC11 and H2AZ1 interacts with VPS72 (via N-terminal domain).

Subcellular location. Nucleus. Chromosome.

Post-translational modifications. Monoubiquitination at Lys-35 (H2BK34Ub) by the MSL1/MSL2 dimer is required for histone H3 ‘Lys-4’ (H3K4me) and ‘Lys-79’ (H3K79me) methylation and transcription activation at specific gene loci, such as HOXA9 and MEIS1 loci. Similarly, monoubiquitination at Lys-121 (H2BK120Ub) by the RNF20/40 complex gives a specific tag for epigenetic transcriptional activation and is also prerequisite for histone H3 ‘Lys-4’ and ‘Lys-79’ methylation. It also functions cooperatively with the FACT dimer to stimulate elongation by RNA polymerase II. H2BK120Ub also acts as a regulator of mRNA splicing: deubiquitination by USP49 is required for efficient cotranscriptional splicing of a large set of exons. Phosphorylation at Ser-37 (H2BS36ph) by AMPK in response to stress promotes transcription. Phosphorylated on Ser-15 (H2BS14ph) by STK4/MST1 during apoptosis; which facilitates apoptotic chromatin condensation. Also phosphorylated on Ser-15 in response to DNA double strand breaks (DSBs), and in correlation with somatic hypermutation and immunoglobulin class-switch recombination. GlcNAcylation at Ser-113 promotes monoubiquitination of Lys-121. It fluctuates in response to extracellular glucose, and associates with transcribed genes. ADP-ribosylated by PARP1 or PARP2 on Ser-7 (H2BS6ADPr) in response to DNA damage. H2BS6ADPr promotes recruitment of CHD1L. Mono-ADP-ribosylated on Glu-3 (H2BE2ADPr) by PARP3 in response to single-strand breaks. Poly ADP-ribosylation on Glu-36 (H2BE35ADPr) by PARP1 regulates adipogenesis: it inhibits phosphorylation at Ser-37 (H2BS36ph), thereby blocking expression of pro-adipogenetic genes. Crotonylation (Kcr) is specifically present in male germ cells and marks testis-specific genes in post-meiotic cells, including X-linked genes that escape sex chromosome inactivation in haploid cells. Crotonylation marks active promoters and enhancers and confers resistance to transcriptional repressors. It is also associated with post-meiotically activated genes on autosomes. Lactylated in macrophages by EP300/P300 by using lactoyl-CoA directly derived from endogenous or exogenous lactate, leading to stimulates gene transcription.

Similarity. Belongs to the histone H2B family.

RefSeq proteins (1): NP_066402* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000558Histone_H2BFamily
IPR007125H2A/H2B/H3Domain
IPR009072Histone-foldHomologous_superfamily
IPR055333HISTONE_H2B_siteConserved_site

Pfam: PF00125

UniProt features (109 total): modified residue 91, helix 4, cross-link 4, strand 3, initiator methionine 1, chain 1, sequence conflict 1, turn 1, region of interest 1, compositionally biased region 1, glycosylation site 1

Structure

Experimental structures (PDB)

304 structures, top 30 by resolution.

PDBMethodResolution (Å)
4CAYX-RAY DIFFRACTION1.48
7VZ4ELECTRON MICROSCOPY1.89
8I17X-RAY DIFFRACTION1.98
5B0ZX-RAY DIFFRACTION1.99
5Y0DX-RAY DIFFRACTION1.99
6IPUX-RAY DIFFRACTION1.99
9INCX-RAY DIFFRACTION2.01
5Y0CX-RAY DIFFRACTION2.09
6JOUX-RAY DIFFRACTION2.17
5X7XX-RAY DIFFRACTION2.18
5AV6X-RAY DIFFRACTION2.2
5AV8X-RAY DIFFRACTION2.2
5AV9X-RAY DIFFRACTION2.2
5B31X-RAY DIFFRACTION2.2
6K1KX-RAY DIFFRACTION2.2
6KVDX-RAY DIFFRACTION2.21
6IQ4X-RAY DIFFRACTION2.25
6JXDX-RAY DIFFRACTION2.25
8KB5ELECTRON MICROSCOPY2.26
5B32X-RAY DIFFRACTION2.35
8JLBELECTRON MICROSCOPY2.36
8YBJELECTRON MICROSCOPY2.38
3AZGX-RAY DIFFRACTION2.4
5AV5X-RAY DIFFRACTION2.4
5AVBX-RAY DIFFRACTION2.4
5AVCX-RAY DIFFRACTION2.4
6JR1X-RAY DIFFRACTION2.4
5Z30X-RAY DIFFRACTION2.45
8JLDELECTRON MICROSCOPY2.48
8VG1ELECTRON MICROSCOPY2.48

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P06899-F185.700.71

Antibody-complex structures (SAbDab): 86E0C, 6E0P, 7K5X, 7K5Y, 7K60, 7K61, 7K63, 8VFX

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (95): 6, 6, 6, 6, 7, 12, 12, 12, 12, 12, 12, 13, 13, 13, 15, 16, 16, 16, 16, 17 …

Glycosylation sites (1): 113

Function

Pathways and Gene Ontology

Reactome pathways

58 pathways

IDPathway
R-HSA-110328Recognition and association of DNA glycosylase with site containing an affected pyrimidine
R-HSA-110329Cleavage of the damaged pyrimidine
R-HSA-110330Recognition and association of DNA glycosylase with site containing an affected purine
R-HSA-110331Cleavage of the damaged purine
R-HSA-1221632Meiotic synapsis
R-HSA-171306Packaging Of Telomere Ends
R-HSA-1912408Pre-NOTCH Transcription and Translation
R-HSA-201722Formation of the beta-catenin:TCF transactivating complex
R-HSA-212300PRC2 methylates histones and DNA
R-HSA-2299718Condensation of Prophase Chromosomes
R-HSA-2559580Oxidative Stress Induced Senescence
R-HSA-2559582Senescence-Associated Secretory Phenotype (SASP)
R-HSA-2559586DNA Damage/Telomere Stress Induced Senescence
R-HSA-3214815HDACs deacetylate histones
R-HSA-3214847HATs acetylate histones
R-HSA-427359SIRT1 negatively regulates rRNA expression
R-HSA-427389ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression
R-HSA-427413NoRC negatively regulates rRNA expression
R-HSA-5250924B-WICH complex positively regulates rRNA expression
R-HSA-5334118DNA methylation
R-HSA-5578749Transcriptional regulation by small RNAs
R-HSA-5617472Activation of anterior HOX genes in hindbrain development during early embryogenesis
R-HSA-5625886Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
R-HSA-5689880Ub-specific processing proteases
R-HSA-5693565Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
R-HSA-5693571Nonhomologous End-Joining (NHEJ)
R-HSA-5693607Processing of DNA double-strand break ends
R-HSA-606279Deposition of new CENPA-containing nucleosomes at the centromere
R-HSA-68616Assembly of the ORC complex at the origin of replication
R-HSA-69473G2/M DNA damage checkpoint

MSigDB gene sets: 284 (showing top): BROWNE_HCMV_INFECTION_30MIN_DN, REACTOME_MEIOTIC_RECOMBINATION, REACTOME_DNA_REPLICATION, REACTOME_SIGNALING_BY_NOTCH, GOBP_ANTIMICROBIAL_HUMORAL_RESPONSE, REACTOME_ADAPTIVE_IMMUNE_SYSTEM, REACTOME_MEIOTIC_SYNAPSIS, GOBP_RESPONSE_TO_PEPTIDE, ENK_UV_RESPONSE_KERATINOCYTE_UP, REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT, GOBP_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY, GOBP_ORGAN_OR_TISSUE_SPECIFIC_IMMUNE_RESPONSE, REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP

GO Biological Process (11): innate immune response in mucosa (GO:0002227), chromatin organization (GO:0006325), nucleosome assembly (GO:0006334), negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804), antibacterial humoral response (GO:0019731), killing of cells of another organism (GO:0031640), defense response to Gram-negative bacterium (GO:0050829), defense response to Gram-positive bacterium (GO:0050830), protein localization to CENP-A containing chromatin (GO:0061644), antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844), defense response to bacterium (GO:0042742)

GO Molecular Function (5): lipopolysaccharide binding (GO:0001530), DNA binding (GO:0003677), structural constituent of chromatin (GO:0030527), protein heterodimerization activity (GO:0046982), protein binding (GO:0005515)

GO Cellular Component (8): nucleosome (GO:0000786), obsolete extracellular space (GO:0005615), nucleus (GO:0005634), nucleoplasm (GO:0005654), cytosol (GO:0005829), CENP-A containing nucleosome (GO:0043505), chromosome (GO:0005694), plasma membrane (GO:0005886)

Reactome top-level categories

Rollup of top-12 pathways:

CategoryPathways
Cellular Senescence3
Depyrimidination2
Depurination2
Epigenetic regulation of gene expression2
Chromatin modifying enzymes2
Negative epigenetic regulation of rRNA expression2
Positive epigenetic regulation of rRNA expression2
Meiosis1
Telomere Maintenance1
Pre-NOTCH Expression and Processing1
TCF dependent signaling in response to WNT1
Mitotic Prophase1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
defense response to bacterium3
antimicrobial humoral response2
chromatin2
cellular anatomical structure2
mucosal immune response1
innate immune response1
cellular component organization1
chromatin organization1
nucleosome organization1
protein-DNA complex assembly1
negative regulation of cytokine-mediated signaling pathway1
regulation of tumor necrosis factor-mediated signaling pathway1
tumor necrosis factor-mediated signaling pathway1
cell killing1
disruption of cell in another organism1
protein localization to chromatin1
protein localization to chromosome, centromeric region1
defense response1
response to bacterium1
lipid binding1
carbohydrate derivative binding1
nucleic acid binding1
structural molecule activity1
protein dimerization activity1
binding1
protein-DNA complex1
intracellular membrane-bounded organelle1
nuclear lumen1
cytoplasm1
nucleosome1
CENP-A containing chromatin1
intracellular membraneless organelle1
membrane1
cell periphery1

Protein interactions and networks

STRING

2420 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
H2BC11PLGP00747874
H2BC11RNF20Q5VTR2836
H2BC11H3C1P02295816
H2BC11H3C14Q71DI3809
H2BC11H3-7Q5TEC6809
H2BC11H3-3AP06351808
H2BC11H3-5Q6NXT2808
H2BC11H3-4Q16695808
H2BC11RNF40O75150772
H2BC11H2AC19P20670762
H2BC11H2AC20Q16777756
H2BC11H4C16P02304747
H2BC11H4C7Q99525744
H2BC11DET1Q7L5Y6725
H2BC11USP22Q9UPT9722

IntAct

109 interactions, top by confidence:

ABTypeScore
H2AC4H2BC11psi-mi:“MI:0915”(physical association)0.850
H2AC4H2BC11psi-mi:“MI:0407”(direct interaction)0.850
H2AXPPM1Gpsi-mi:“MI:0914”(association)0.730
H2AC4PPM1Gpsi-mi:“MI:0914”(association)0.670
H2BC1PPM1Gpsi-mi:“MI:0914”(association)0.640
CBX1ZNF292psi-mi:“MI:0914”(association)0.530
MACROH2A2PPM1Gpsi-mi:“MI:0914”(association)0.530
H2AC18PPM1Gpsi-mi:“MI:0914”(association)0.530
VCAM1PSMD11psi-mi:“MI:0914”(association)0.530
ERBB2HAX1psi-mi:“MI:0914”(association)0.530
psi-mi:“MI:0915”(physical association)0.500
ACTR5H2AC4psi-mi:“MI:0915”(physical association)0.460
ACTR5H2AC4psi-mi:“MI:0914”(association)0.460
ANP32EH2BC11psi-mi:“MI:0407”(direct interaction)0.440
PPM1GH2BC12psi-mi:“MI:0914”(association)0.420
PPM1GH2BC12psi-mi:“MI:2364”(proximity)0.420
H2BC11TLX3psi-mi:“MI:0915”(physical association)0.370
JMJD6H2BC11psi-mi:“MI:0915”(physical association)0.370
CREB1NFIXpsi-mi:“MI:0914”(association)0.350

BioGRID (400): HIST1H2BJ (Affinity Capture-MS), HIST1H2BJ (Affinity Capture-MS), HIST1H2BJ (Affinity Capture-MS), HIST1H2BJ (Affinity Capture-MS), HIST1H2BJ (Affinity Capture-MS), HIST1H2BJ (Affinity Capture-MS), HIST1H2BJ (Affinity Capture-MS), HIST1H2BJ (Biochemical Activity), PARP9 (Affinity Capture-Western), DTX3L (Affinity Capture-Western), STAT1 (Affinity Capture-Western), HIST1H2BJ (Affinity Capture-Western), FGA (Affinity Capture-MS), FGB (Affinity Capture-MS), FGG (Affinity Capture-MS)

ESM2 similar proteins: A1CJ09, A1D8G9, A2QY49, A3LXE6, A3LZZ1, A5DBG5, A5DJJ1, A5DWF0, L7I1W3, P02281, P02293, P02294, P04255, P04913, P06899, P0C1H5, P0CO02, P0CO03, P0CT13, P10853, P23754, P37210, P48989, P78567, Q0CBD1, Q1E5N0, Q1SU99, Q27484, Q27876, Q27894, Q2HH38, Q2U5A9, Q43217, Q4HTT2, Q4PEF8, Q4WWC5, Q59VP1, Q5RCP8, Q6BKW7, Q6BRG2

Diamond homologs: A0A2R8Y619, A2WKT1, A2WKT4, A2WWU2, A2XF66, A2YWI3, A3AGM4, O22582, O60814, O65819, P02281, P02283, P02284, P02285, P02286, P02287, P02288, P02289, P02290, P04255, P06145, P06899, P06900, P07794, P07795, P0C1H3, P0C1H4, P0C1H5, P10853, P10854, P14001, P16888, P16889, P16890, P17271, P19374, P21897, P23527, P27326, P27807

SIGNOR signaling

8 interactions.

AEffectBMechanism
H2BC11“form complex”“Nucleosome_H3.3 variant”binding
SLBP“up-regulates quantity by expression”H2BC11“translation regulation”
“MSL acetyltransferase”“down-regulates activity”H2BC11monoubiquitination
H2BC11“form complex”“CENP-A nucleosome”binding
H2BC11“form complex”“Nucleosome_H2A.Z.2 variant”binding
H2BC11“form complex”“Nucleosome_H2A.Z.1 variant”binding
H2BC11“form complex”“Nucleosome_H3.1 variant”binding
H2BC11“form complex”“Nucleosome_H3.1t variant”binding

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 100 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Transcriptional regulation of granulopoiesis1119.2×6e-09
ChAHP complex assembly615.3×2e-04
Packaging Of Telomere Ends515.2×8e-04
SIRT1 negatively regulates rRNA expression614.2×3e-04
Recognition and association of DNA glycosylase with site containing an affected purine514.2×9e-04
Cleavage of the damaged purine514.2×9e-04
Inhibition of DNA recombination at telomere614.0×3e-04
Regulation of PD-L1(CD274) transcription913.6×6e-06

GO biological processes:

GO termPartnersFoldFDR
mRNA transcription by RNA polymerase II518.6×2e-03
heterochromatin formation617.2×7e-04
positive regulation of miRNA transcription516.3×2e-03
response to ethanol711.5×9e-04
nucleosome assembly69.5×5e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

25 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance25
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

409 predictions. Top by Δscore:

VariantEffectΔscore
6:27132365:A:ACdonor_gain1.0000
6:27132366:C:CCdonor_gain1.0000
6:27132376:A:ACdonor_gain1.0000
6:27132376:AG:Adonor_gain1.0000
6:27132376:AGCG:Adonor_gain1.0000
6:27132377:G:Cdonor_gain1.0000
6:27126459:CCAC:Cacceptor_gain0.9900
6:27126460:CACC:Cacceptor_gain0.9900
6:27132361:ACT:Adonor_loss0.9900
6:27132362:C:Gdonor_loss0.9900
6:27132362:CTCA:Cdonor_gain0.9900
6:27132363:TCACT:Tdonor_loss0.9900
6:27132364:CA:Cdonor_loss0.9900
6:27132365:AC:Adonor_loss0.9900
6:27132366:CT:Cdonor_gain0.9900
6:27132366:CTG:Cdonor_gain0.9900
6:27132372:A:ACdonor_gain0.9900
6:27132373:C:CCdonor_gain0.9900
6:27132390:TGGTG:Tdonor_gain0.9900
6:27132403:AGTAC:Adonor_gain0.9900
6:27126460:CAC:Cacceptor_gain0.9800
6:27126460:CACCT:Cacceptor_loss0.9800
6:27126461:ACC:Aacceptor_loss0.9800
6:27126463:C:CCacceptor_gain0.9800
6:27126463:CT:Cacceptor_loss0.9800
6:27126464:T:Gacceptor_loss0.9800
6:27127401:CCTT:Cacceptor_gain0.9800
6:27127400:CCCTT:Cacceptor_gain0.9700
6:27127412:C:CTacceptor_gain0.9700
6:27127413:A:Tacceptor_gain0.9700

AlphaMissense

814 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
6:27132400:C:AK117N1.000
6:27132400:C:GK117N1.000
6:27132407:C:AG115V1.000
6:27132407:C:TG115D1.000
6:27132408:C:AG115C1.000
6:27132408:C:GG115R1.000
6:27132419:G:TA111D1.000
6:27132431:A:CL107W1.000
6:27132431:A:GL107S1.000
6:27132437:C:AG105V1.000
6:27132437:C:TG105E1.000
6:27132438:C:AG105W1.000
6:27132449:A:GL101P1.000
6:27132458:G:TA98D1.000
6:27132459:C:GA98P1.000
6:27132463:C:AQ96H1.000
6:27132463:C:GQ96H1.000
6:27132471:C:TE94K1.000
6:27132472:C:AR93S1.000
6:27132472:C:GR93S1.000
6:27132473:C:AR93M1.000
6:27132519:C:GA78P1.000
6:27132545:T:AD69V1.000
6:27132608:T:GQ48P1.000
6:27132614:A:GL46P1.000
6:27132395:A:TV119D0.999
6:27132398:G:TA118D0.999
6:27132399:C:GA118P0.999
6:27132402:T:CK117E0.999
6:27132404:G:AT116I0.999

dbSNP variants (sampled 300 via entrez): RS1000107163 (6:27131958 G>A), RS1001283944 (6:27133597 C>T), RS1001313399 (6:27133468 T>C), RS1002289581 (6:27134532 T>C), RS1002319247 (6:27134237 A>C), RS1004388343 (6:27134226 A>G), RS1004761593 (6:27134472 T>G), RS1005075620 (6:27132276 C>T), RS1006198827 (6:27133752 A>G), RS1006537220 (6:27131999 G>A,C), RS1006766102 (6:27132233 CA>C,CAA), RS1007849734 (6:27133891 G>A,T), RS1008207013 (6:27132727 A>G), RS1008298911 (6:27132812 G>A), RS1008424451 (6:27133744 A>G)

Disease associations

OMIM: gene MIM:615044 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

24 associations (top):

StudyTraitp-value
GCST000301_13Iron status biomarkers1.000000e-08
GCST000433_1Schizophrenia1.000000e-08
GCST004521_113Autism spectrum disorder or schizophrenia3.000000e-19
GCST004521_116Autism spectrum disorder or schizophrenia3.000000e-16
GCST004521_166Autism spectrum disorder or schizophrenia4.000000e-24
GCST004521_208Autism spectrum disorder or schizophrenia5.000000e-17
GCST004521_215Autism spectrum disorder or schizophrenia5.000000e-13
GCST004521_286Autism spectrum disorder or schizophrenia5.000000e-08
GCST004521_57Autism spectrum disorder or schizophrenia1.000000e-20
GCST004521_69Autism spectrum disorder or schizophrenia8.000000e-24
GCST004571_23Iron status biomarkers (total iron binding capacity)2.000000e-08
GCST004572_4Iron status biomarkers (transferrin saturation)2.000000e-08
GCST010002_50Refractive error4.000000e-34
GCST010142_16Fish- and plant-related diet2.000000e-10
GCST010142_19Fish- and plant-related diet4.000000e-10
GCST010142_34Fish- and plant-related diet7.000000e-09
GCST010142_35Fish- and plant-related diet8.000000e-09
GCST010142_42Fish- and plant-related diet1.000000e-08
GCST010142_7Fish- and plant-related diet3.000000e-12
GCST010142_74Fish- and plant-related diet9.000000e-09
GCST010142_82Fish- and plant-related diet3.000000e-08
GCST010702_75Subcortical volume (MOSTest)3.000000e-11
GCST010703_272Brain morphology (MOSTest)7.000000e-16
GCST90016674_5Liver iron content2.000000e-135

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0004461iron biomarker measurement
EFO:0006334total iron binding capacity
EFO:0008111diet measurement
EFO:0004346neuroimaging measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

47 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteincreases expression, affects binding, increases reaction, decreases expression6
(+)-JQ1 compoundincreases expression5
Air Pollutantsdecreases expression, affects cotreatment, increases abundance, increases expression4
Benzo(a)pyreneincreases expression, decreases methylation3
bisphenol Adecreases expression, increases expression2
Acetaminophenincreases expression2
Doxorubicinaffects expression2
Silicon Dioxideincreases expression2
Tobacco Smoke Pollutiondecreases expression, affects expression2
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxidedecreases expression, increases expression2
Particulate Matterdecreases expression, increases abundance2
aristolochic acid Iincreases expression1
UF010 compoundincreases acetylation1
OTX015affects expression1
alpha-pineneaffects cotreatment, increases expression, increases abundance1
trichostatin Aaffects expression1
thallium sulfatedecreases expression1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
perfluorooctanoic aciddecreases expression1
ferrous chlorideincreases expression1
methacrylaldehydeincreases abundance, affects cotreatment, increases expression1
homosalateaffects cotreatment, increases expression1
obeticholic aciddecreases expression1
abrineincreases expression1
Poly(amidoamine)increases expression1
licochalcone Bincreases expression1
jinfukangaffects cotreatment, increases expression1
incobotulinumtoxinAdecreases expression1
Leflunomideincreases expression1
Acroleinaffects cotreatment, increases expression, increases abundance1

Cellosaurus cell lines

30 cell lines: 17 cancer cell line, 10 embryonic stem cell, 3 induced pluripotent stem cell

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_1D62HeLa Kyoto EGFP-LaminA/H2B-mCherryCancer cell lineFemale
CVCL_1D63HeLa Kyoto EGFP-H2BCancer cell lineFemale
CVCL_1D65HeLa Kyoto Mad2-LAP/H2B-mCherryCancer cell lineFemale
CVCL_A2AYYUMMER1.7 H2B-GFP5Cancer cell lineMale
CVCL_A5NJH7-H2B-RFPEmbryonic stem cellFemale
CVCL_A5NKH14-H2B-RFPEmbryonic stem cellMale
CVCL_A5NLHUES 17-H2B-RFPEmbryonic stem cellMale
CVCL_A7QQU2OS EGFP-H2BCancer cell lineFemale
CVCL_C4SECCMB-Me-14-STGG-A1Embryonic stem cellMale
CVCL_E7GGH9 NR4A2-eGFPEmbryonic stem cellFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.